Clinical outcomes of the propensity match analysis comparing patients treated with the CONCORDE Bullet with matched patients treated with alternative therapies
| Outcomes: Propensity match analysis | CONCORDE Bullet (%) | Alternative IVBI (%) | Relative risk | 95% CI | P value | ||
| (n=69) | (n=69) | ||||||
| Primary endpoint: | |||||||
| Reoperation at 1 year | 1 | 1.4 | 0 | 0.0 | n/a | n/a | 0.316 |
| Secondary endpoints: | |||||||
| Mortality at 1 year | 1 | 1.4 | 0 | 0.0 | n/a | n/a | 0.316 |
| Any hospitalization at 1 year | 15 | 21.7 | 7 | 10.1 | 2.14 | (0.93 to 4.93) | 0.063 |
| Blood transfusion (postoperative) | 7 | 10.1 | 3 | 4.3 | 2.33 | (0.63 to 8.66) | 0.189 |
| Surgical site infection | 0 | 0.0 | 0 | 0.0 | n/a | n/a | n/a |
IVBI, intervertebral body implant.